Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Hamoud Shulaywih Alshaman"'
Autor:
Galal Yahya, Nashwa Hashem Mohamed, Jordi Pijuan, Noura M. Seleem, Rasha Mosbah, Steffen Hess, Ahmed A. Abdelmoaty, Rafa Almeer, Mohamed M. Abdel‐Daim, Hamoud Shulaywih Alshaman, Ibrahim Juraiby, Kamel Metwally, Zuzana Storchova
Publikováno v:
Microbial Biotechnology, Vol 14, Iss 5, Pp 2199-2213 (2021)
Summary Sofosbuvir and Daclatasvir are among the direct‐acting antiviral (DAA) medications prescribed for the treatment of chronic hepatitis C (CHC) virus infection as combination therapy with other antiviral medications. DAA‐based therapy achiev
Externí odkaz:
https://doaj.org/article/2ce7ec8a309f4682b860b2720fa41ac1
Autor:
Steffen Hess, Ahmed A Abdelmoaty, Kamel Metwally, Noura M. Seleem, Ibrahim Juraiby, Mohamed M. Abdel-Daim, Rafa Almeer, Nashwa H Mohamed, Zuzana Storchova, Jordi Pijuan, Rasha A Mosbah, Hamoud Shulaywih Alshaman, Galal Yahya
Publikováno v:
Microbial Biotechnology, Vol 14, Iss 5, Pp 2199-2213 (2021)
Summary Sofosbuvir and Daclatasvir are among the direct‐acting antiviral (DAA) medications prescribed for the treatment of chronic hepatitis C (CHC) virus infection as combination therapy with other antiviral medications. DAA‐based therapy achiev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c37d71b8ccd71f1c6ec1d1c1ef053719
https://doaj.org/article/2ce7ec8a309f4682b860b2720fa41ac1
https://doaj.org/article/2ce7ec8a309f4682b860b2720fa41ac1